Researchers from Eindhoven University of Technology (TU/e) and Keio University today present a practicable and reliable way to test for infectious diseases.
All you need are a special glowing paper strip, a drop of blood and a digital camera, as they write in the scientific journal Angewandte Chemie. Not only does this make the technology very cheap and fast – after twenty minutes it is clear whether there is an infection – it also makes expensive and time-consuming laboratory measurements in the hospital unnecessary. In addition, the test has a lot of potential in developing countries for the easy testing of tropical diseases.
The test shows the presence of infectious diseases by searching for certain antibodies in the blood that your body makes in response to, for example, viruses and bacteria. The development of handy tests for the detection of antibodies is in the spotlight as a practicable and quick alternative to expensive, time-consuming laboratory measurements in hospitals. Doctors are also increasingly using antibodies as medicines, for example in the case of cancer or rheumatism. So this simple test is also suitable for regularly monitoring the dose of such medicines to be able to take corrective measures in good time.
The use of the paper strip developed by the Dutch and Japanese researchers is a piece of cake. Apply a drop of blood to the appropriate place on the paper, wait twenty minutes and turn it over. “A biochemical reaction causes the underside of paper to emit blue-green light,” says Eindhoven University of Technology professor and research leader Maarten Merkx. “The bluer the color, the higher the concentration of antibodies.” A digital camera, for example from a mobile phone, is sufficient to determine the exact color and thus the result.
The color is created thanks to the secret ingredient of the paper strip: a so-called luminous sensor protein developed at TU/e. After a droplet of blood comes onto the paper, this protein triggers a reaction in which blue light is produced (known as bioluminescence). An enzyme that also illuminates fireflies and certain fish, for example, plays a role in this. In a second step, the blue light is converted into green light. But here comes the clue: if an antibody binds to the sensor protein, it blocks the second step. A lot of green means few antibodies and, vice versa, less green means more antibodies.
The ratio of blue and green light can be used to derive the concentration of antibodies. “So not only do you know whether the antibody is in the blood, but also how much,” says Merkx. By measuring the ratio precisely, they suffer less from problems that other biosensors often have, such as the signal becoming weaker over time. In their prototype, they successfully tested three antibodies simultaneously, for HIV, flu and dengue fever. Merkx expects the test to be commercially available within a few years.
The Latest on: Test for infectious diseases
via Google News
The Latest on: Test for infectious diseases
- Clearfield, Fulton County deer test positive for CWD on February 20, 2019 at 5:50 pm
Both farms will remain under quarantine for five years from the date the positive tests were ... The infectious agent, known as a prion, tends to concentrate in the brain, spinal column, eyes, spleen, ... […]
- Abbott receives CE Mark for rapid diagnostic HBV surface antigen test on February 20, 2019 at 10:36 am
Abbott received CE Mark for the company’s Determine HBsAg 2 test, a rapid diagnostic test designed to ... regions in Africa and Asia,” Damian Halloran, vice president of Infectious Disease-Emerging Ma... […]
- A new model for disease research in Africa on February 20, 2019 at 3:10 am
Realizing how strongly they are all connected, 196 countries promised at the World Health Assembly in Geneva, Switzerland, to work together to strengthen each nation’s ability to detect, report and re... […]
- CDC Endorsement of Single Dose Antibiotic for Lyme Disease Prevention Challenged on February 19, 2019 at 7:07 am
The recommendation on tick bite prophylaxis is from the Infectious Diseases Society of America ... this partial treatment has been shown to result in false negative blood test results for Lyme disease ... […]
- Infectious Disease Diagnostics Market to Surpass US$ 20 Billion by 2024 on February 19, 2019 at 6:56 am
However, these test are expected to replace by molecular techniques in future. The Global Infectious Disease Diagnostics Market is expected to exceed more than US$ 20 Billion by 2024 at a CAGR of 5% i... […]
- Danazol Treatment for Telomere Diseases on February 18, 2019 at 5:10 pm
In a phase 1–2 prospective study involving patients with telomere diseases, we administered the synthetic sex ... telomeres function to protect the chromosome ends from recognition as damaged or infec... […]
- Infectious Disease Testing Market Trend, Growth and Forecast to 2023: Top Key Players Hologic, Abbott Diagnostics, Alere, Siemens Healthcare on February 13, 2019 at 8:47 am
Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media. The global Infectious Disease Testing market is valued at xx million in 2017 a... […]
- SpeeDx expands their infectious disease portfolio into respiratory market on February 12, 2019 at 8:55 pm
The test utilizes SpeeDx market-leading PlexPCR® multiplex technology, designed for detection of 14 targets representing 10 viral respiratory-illness causing pathogens. "We are excited to expand our i... […]
- Infectious disease diagnostic tool outperforms standard testing methods, study finds on February 12, 2019 at 4:35 pm
Researchers validated a blood test for detecting infectious pathogens and found the test outperforms standard diagnostic methods, according to a study published in Nature Microbiology. Life sciences c... […]
via Bing News